Paul E. Hurtubise

1.8k total citations
60 papers, 1.4k citations indexed

About

Paul E. Hurtubise is a scholar working on Immunology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Paul E. Hurtubise has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Pathology and Forensic Medicine and 11 papers in Epidemiology. Recurrent topics in Paul E. Hurtubise's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Paul E. Hurtubise is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Paul E. Hurtubise collaborates with scholars based in United States and China. Paul E. Hurtubise's co-authors include Albert F. LoBuglio, Gerald W. King, Robert P. Baughman, Arthur L. Sagone, Carol H. Bosken, Robert S. Bar, Werner Henle, John F. Hewetson, Karen James and Kathryn P. Clausen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Paul E. Hurtubise

59 papers receiving 1.2k citations

Peers

Paul E. Hurtubise

IMMUN

ONCOL

PFM

GENET

PRM

Kiyoshi Kitano Japan

Leonard Ellman United States

Niels Ebbe Hansen Denmark

Hirobumi Kondo Japan

Gunnar Öberg Sweden

Michael Nardi United States

Robert R. Chilcote United States

Evelyne T. Edwards United States

K. Bross Germany

Sylvie Caulet-Maugendre France

Kiyoshi Kitano Japan

Paul E. Hurtubise

483 ×1.2

IMMUN

266 ×0.8

ONCOL

194 ×0.9

PFM

243 ×1.1

GENET

286 ×1.3

PRM

Citations per year, relative to Paul E. Hurtubise Paul E. Hurtubise (= 1×) peers Kiyoshi Kitano

Countries citing papers authored by Paul E. Hurtubise

Since Specialization

Citations

This map shows the geographic impact of Paul E. Hurtubise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Hurtubise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Hurtubise more than expected).

Fields of papers citing papers by Paul E. Hurtubise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Hurtubise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Hurtubise. The network helps show where Paul E. Hurtubise may publish in the future.

Co-authorship network of co-authors of Paul E. Hurtubise

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Hurtubise. A scholar is included among the top collaborators of Paul E. Hurtubise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Hurtubise. Paul E. Hurtubise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crawford, Jeffrey, Philip Bonomi, John D. Hainsworth, et al.. (2009). A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 32(3). 269–273. 25 indexed citations

Sheridan, Rachel, et al.. (2006). Comparison of bone marrow and peripheral blood ZAP‐70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia. Cytometry Part B Clinical Cytometry. 70B(4). 319–320. 6 indexed citations

Stewart, Carleton C., Frederick G. Behm, John L. Carey, et al.. (1997). U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations. Cytometry. 30(5). 231–235. 44 indexed citations

Noffsinger, Amy, et al.. (1995). The relationship of human papillomavirus to proliferation and ploidy in carcinoma of the anus. Cancer. 75(4). 958–967. 15 indexed citations

Keren, David F., Curtis A. Hanson, & Paul E. Hurtubise. (1994). Flow cytometry and clinical diagnosis. 15 indexed citations

Koelliker, Daniel D., et al.. (1994). CD8-Positive B-Cell Chronic Lymphocytic Leukemia:A Report of Two Cases. American Journal of Clinical Pathology. 102(2). 212–216. 14 indexed citations

Pesce, Amadeo J., et al.. (1992). Pharmacokinetics of Zidovudine Phosphorylation in Patients Infected with the Human Immunodeficiency Virus. Therapeutic Drug Monitoring. 14(4). 281–285. 27 indexed citations

Giorgi, Janis V., Paul E. Hurtubise, L. Scott Cram, Jōhn W. Parker, & Mariano F. La Via. (1992). Clinical Applications of Cytometry: 6th Annual Meeting. Cytometry. 13(4). 445–447. 1 indexed citations

Banavali, Shripad, Federico Silvestri, Ben C. Hulette, et al.. (1991). Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia. Leukemia Research. 15(7). 603–608. 12 indexed citations

10.

Pesce, Amadeo J., et al.. (1991). Concentrations of Phosphorylated Zidovudine (ZDV) in Patient Leukocytes Do Not Correlate with ZDV Dose or Plasma Concentrations. Therapeutic Drug Monitoring. 13(4). 325–331. 36 indexed citations

11.

Bendon, Robert W., Paul E. Hurtubise, Tariq Jamal Siddiqi, et al.. (1990). Prenatal Screening for Anticardiolipin Antibody. American Journal of Perinatology. 7(3). 245–250. 4 indexed citations

12.

Pesce, Amadeo J., et al.. (1990). In Vitro Measurement of Phosphorylated Zidovudine in Peripheral Blood Leucocytes. Therapeutic Drug Monitoring. 12(5). 481–489. 18 indexed citations

13.

First, M. Roy, Paul E. Hurtubise, Sundaram Hariharan, et al.. (1990). ANTIMURINE ANTIBODY FORMATION FOLLOWING OKT3 THERAPY. Transplantation. 49(1). 48–51. 49 indexed citations

14.

Schroeder, Timothy, et al.. (1990). Failure of orthoclone okt3 retreatment in a pancreas transplant recipient with antimurine antibodies. Journal of Clinical Laboratory Analysis. 4(2). 99–101. 1 indexed citations

15.

Hurtubise, Paul E., et al.. (1990). Flow-cytometric DNA analysis of hematopoietic and lymphoid proliferations: A comparison of fresh, formalin-fixed and B5-fixed tissues. Human Pathology. 21(5). 551–558. 4 indexed citations

16.

Steele, Paul E., et al.. (1990). Multilobated lymphoma of B cell type: A multiparameter investigation. Human Pathology. 21(10). 1036–1040. 5 indexed citations

17.

Schroeder, Timothy J., Paul E. Hurtubise, Mona E. Mansour, et al.. (1989). SUCCESSFUL RETREATMENT OF ALLOGRAFT REJECTION WITH OKT3. Transplantation. 47(1). 88–91. 33 indexed citations

18.

Schroeder, Timothy J., David Melvin, Rino Munda, et al.. (1988). OKT3 therapy in kidney, liver, heart, and pancreas transplantation. Clinical Transplantation. 2(4). 185–189. 9 indexed citations

19.

Baughman, Robert P., Alan M. Solinger, Paul E. Hurtubise, et al.. (1983). BRONCHO ALVEOLAR LAVAGE IN PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) ^1,2. PubMed. 1(2). 91–97. 2 indexed citations

20.

Sahenk, Zarife, Jerry R. Mendell, Jeffrey L. Rossio, & Paul E. Hurtubise. (1977). Polyradiculoneuropathy accompaning procainamide‐induced lupus erythematosus: Evidence for drug‐induced enhanced sensitization to peripheral nerve myelin. Annals of Neurology. 1(4). 378–384. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact